| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-07 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-06 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |